{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:03:35Z","timestamp":1786989815733,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007181","name":"Biotechnology Research Center, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.gene.2020.145236","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:24:36Z","timestamp":1602717876000},"page":"145236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus na\u00efve patients and healthy controls"],"prefix":"10.1016","volume":"769","author":[{"given":"Shima","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-0854","authenticated-orcid":false,"given":"Saeed","family":"Noorolyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hormoz","family":"Ayromlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Khaze Shahgoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Shanehbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Baghbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Abdoli Shadbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farinaz","family":"Jigari-Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Khamiriyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6970-6998","authenticated-orcid":false,"given":"Reza","family":"Safaralizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gene.2020.145236_b0005","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/1352458516686847","article-title":"Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop","volume":"24","author":"Amato","year":"2018","journal-title":"Multiple Sclerosis J."},{"issue":"1\u20132","key":"10.1016\/j.gene.2020.145236_b0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jns.2015.10.007","article-title":"Demonstration of equivalence of a generic glatiramer acetate (Glatopa\u2122)","volume":"359","author":"Anderson","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.gene.2020.145236_b0015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-genet-120213-092323","article-title":"Regulation of transcription by long non-coding RNAs","volume":"48","author":"Bonasio","year":"2014","journal-title":"Annu. Rev. Genet."},{"issue":"6","key":"10.1016\/j.gene.2020.145236_b0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/cells8060533","article-title":"Distinct expression of inflammatory features in T helper 17 cells from multiple sclerosis patients","volume":"8","author":"Capone","year":"2019","journal-title":"Cells"},{"issue":"6147","key":"10.1016\/j.gene.2020.145236_b0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1240925","article-title":"A long non-coding RNA mediates both activation and repression of immune response genes","volume":"341","author":"Carpenter","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gene.2020.145236_b0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4049\/jimmunol.0900193","article-title":"Regulatory properties of copolymer I in Th17 differentiation by altering STAT3 phosphorylation","volume":"183","author":"Chen","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.gene.2020.145236_b0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.gene.2020.145236_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.gene.2020.145236_b0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/WCO.0000000000000094","article-title":"Relapsing and progressive forms of multiple sclerosis\u2013insights from pathology","volume":"27","author":"Dutta","year":"2014","journal-title":"Curr. Opin. Neurol."},{"issue":"9139","key":"10.1016\/j.gene.2020.145236_b0050","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon \u03b2-1a in relapsing\/remitting multiple sclerosis","volume":"352","author":"Ebers","year":"1998","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.gene.2020.145236_b0055","first-page":"25","article-title":"Epigenetic mechanisms in multiple sclerosis","volume":"6","author":"Gacias","year":"2014","journal-title":"Revista espanola de esclerosis multiple."},{"key":"10.1016\/j.gene.2020.145236_b0060","doi-asserted-by":"crossref","unstructured":"Group IMSS. Interferon beta\u20101b is effective in relapsing\u2010remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double\u2010blind, placebo-controlled trial. Neurology. 1993;43(4):655-.","DOI":"10.1212\/WNL.43.4.655"},{"key":"10.1016\/j.gene.2020.145236_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101407","article-title":"Long non-coding RNAs associated with phenotypic severity in multiple sclerosis","volume":"36","author":"Gupta","year":"2019","journal-title":"Multiple Sclerosis Related Disord."},{"issue":"3","key":"10.1016\/j.gene.2020.145236_b0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17-producing T cells in inflammatory responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.gene.2020.145236_b0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13073-014-0088-0","article-title":"Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell-type specificity","volume":"6","author":"Hrdlickova","year":"2014","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.gene.2020.145236_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01571-8","article-title":"Transcriptional signature of human pro-inflammatory TH 17 cells identifies reduced IL10 gene expression in multiple sclerosis","volume":"8","author":"Hu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2020.145236_b0085","doi-asserted-by":"crossref","unstructured":"Huang W, Littman DR, editors. Regulation of ROR\u03b3t in inflammatory lymphoid cell differentiation. Cold Spring Harbor symposia on quantitative biology; 2015: Cold Spring Harbor Laboratory Press.","DOI":"10.1101\/sqb.2015.80.027615"},{"issue":"2","key":"10.1016\/j.gene.2020.145236_b0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(12)70309-5","article-title":"Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment","volume":"12","author":"Huynh","year":"2013","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.gene.2020.145236_b0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of pro-inflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gene.2020.145236_b0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410390304","article-title":"Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis","volume":"39","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"issue":"13","key":"10.1016\/j.gene.2020.145236_b0105","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.gene.2020.145236_b0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2020.145236_b0115","article-title":"Long non-coding RNAs in immune regulation and their potential as therapeutic targets","volume":"81","author":"Kumar","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.gene.2020.145236_b0120","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3908061","article-title":"The role of IL-17 and related cytokines in inflammatory autoimmune diseases","volume":"2017","author":"Kuwabara","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.gene.2020.145236_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4+ T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Develop. Immunol."},{"key":"10.1016\/j.gene.2020.145236_b0130","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3389\/fimmu.2018.01693","article-title":"Immunophenotype and transcriptome profile of patients with multiple sclerosis treated with fingolimod: Setting up a model for prediction of response in a 2-year translational study","volume":"9","author":"Moreno-Torres","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.gene.2020.145236_b0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.it.2017.08.009","article-title":"Control of immune cell homeostasis and function by lncRNAs","volume":"39","author":"Mowel","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.gene.2020.145236_b0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fnagi.2018.00238","article-title":"Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions","volume":"10","author":"Musella","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.gene.2020.145236_b0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.gene.2020.145236_b0150","doi-asserted-by":"crossref","unstructured":"S Ramgolam V, Markovic-Plese S. Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2010;10(2):161-7.","DOI":"10.2174\/187153010791213029"},{"issue":"1\u20132","key":"10.1016\/j.gene.2020.145236_b0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2014.01.008","article-title":"Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis","volume":"268","author":"Sato","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.gene.2020.145236_b0160","doi-asserted-by":"crossref","unstructured":"Soldan SS, Wu G, Markowitz C, Kolson DL. Multiple sclerosis and other demyelinating diseases. Neuroimmune Pharmacology: Springer; 2008. p. 239-55.","DOI":"10.1007\/978-0-387-72573-4_18"},{"issue":"1","key":"10.1016\/j.gene.2020.145236_b0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.gene.2020.145236_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/imr.12204","article-title":"Transcriptional and epigenetic regulation of T-helper lineage specification","volume":"261","author":"Tripathi","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.gene.2020.145236_b0175","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.isci.2018.12.020","article-title":"Quantitative proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization","volume":"11","author":"Tripathi","year":"2019","journal-title":"Iscience."},{"issue":"11","key":"10.1016\/j.gene.2020.145236_b0180","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","article-title":"Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation","volume":"76","author":"Tsai","year":"2016","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.gene.2020.145236_b0185","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2014.01.002","article-title":"The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-\u03b3-producing T helper 17 cells","volume":"40","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.gene.2020.145236_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-00636-z","article-title":"Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases","volume":"27","author":"Wu","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"8","key":"10.1016\/j.gene.2020.145236_b0195","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.4049\/jimmunol.1601532","article-title":"Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1\/Th17 and Th2 in multiple sclerosis patients","volume":"198","author":"Wu","year":"2017","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.gene.2020.145236_b0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.coi.2009.03.001","article-title":"Transcriptional regulatory networks in Th17 cell differentiation","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr. Opin. Immunol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111920309057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111920309057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:43:28Z","timestamp":1759855408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111920309057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":40,"alternative-id":["S0378111920309057"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2020.145236","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus na\u00efve patients and healthy controls","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2020.145236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"145236"}}